Han, Hye Rim <br/><br/>
Evaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma.  [electronic resource] 

 -  Anticancer research  Dec 2019 
 - 6635-6643 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-7530 
<br/><br/><label>Standard No.: </label>10.21873/anticanres.13878  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases--antagonists & inhibitors<br/>Animals<br/>Apoptosis<br/>Brain Neoplasms--metabolism<br/>CASP8 and FADD-Like Apoptosis Regulating Protein--metabolism<br/>Caspase 3--metabolism<br/>Combined Modality Therapy<br/>Glioblastoma--metabolism<br/>Heterografts<br/>Humans<br/>Male<br/>Mesenchymal Stem Cell Transplantation<br/>Mesenchymal Stem Cells--metabolism<br/>Mice<br/>Mice, Nude<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Pyrazoles--therapeutic use<br/>Pyrimidines--therapeutic use<br/>TNF-Related Apoptosis-Inducing Ligand--metabolism<br/>X-Linked Inhibitor of Apoptosis Protein--metabolism<br/>bcl-2-Associated X Protein--metabolism